Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;90(9):1137-41.
doi: 10.1136/bjo.2006.093211. Epub 2006 May 17.

Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema

C K M Chan  1 , S Mohamed, M P Shanmugam, C-W Tsang, T Y Y Lai, D S C Lam
Affiliations

Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema

C K M Chan et al. Br J Ophthalmol. 2006 Sep.

Abstract

Background/aim: Intravitreal triamcinolone (IVTA) results in transient improvements in diabetic macular oedema (DMO), necessitating repeated injections. The authors report a case series of 10 eyes of 10 patients with DMO, who received a repeat injection of 4 mg IVTA, at least 26 weeks after the first injection of the same dose.

Method: Pre-injection and at 2, 4, 9, and 17 weeks post-injection, best corrected visual acuity (BCVA) and central foveal thickness (CFT) on optical coherence tomography, after the first and repeat injections, were compared using paired t test. Side effects were monitored.

Results: BCVA, CFT, intraocular pressure (IOP), and cataract scores were not significantly different before initial and repeat injections (given at 32.5 (SD 3.5) weeks after the first injection). Transient improvements of BCVA and CFT were achieved after both injections. However, after the repeat injection, the BCVA was significantly worse at all time points (p<0.05) and so were the best achieved CFT and the CFT at 4 weeks post-injection (p = 0.034 and 0.011 respectively), compared with the initial injection. Post-injection maximum IOPs and increase in cataract scores were not significantly different between the two injections.

Conclusion: A repeat injection of 4 mg of IVTA may not be as effective as an initial injection for the treatment of DMO.

PubMed Disclaimer

Conflict of interest statement

Competing interests: nil.

Comment in

References

    1. Jonas J B, Akkoyun I, Kreissig I.et al Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non‐randomised study. Br J Ophthalmol 200589321–326. - PMC - PubMed
    1. Lam D S, Chan C K, Mohamed S.et al Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6‐month prospective pilot study. Eye 200519885–890. - PubMed
    1. Lam D S, Chan C K, Tang E W.et al Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six‐month prospective longitudinal pilot study. Clin Experiment Ophthalmol 200432569–572. - PubMed
    1. Ozkiris A, Evereklioglu C, Erkilic K.et al Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 200414543–549. - PubMed
    1. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005140695–702. - PubMed

MeSH terms